Associate Director of Advanced Drug Delivery and Regenerative Biomaterials @ (January 2021 - Present)
Co-Founder @ (January 2020 - January 2024)
Scientist @ (January 2020 - January 2021)
Postdoctoral Fellow @ (January 2015 - January 2020)
PhD Candidate @ (January 2007 - January 2015)
Undergraduate Student Researcher @ (January 2005 - January 2007)
Kyle Brewer Education
UT Southwestern Medical Center
PhD Molecular Biophysics
2007-2014
North Carolina State University
BS Biochemistry (BA Chemistry)
2003-2007
Kyle Brewer Skills
Adeno-associated virus (AAV) Production
Advertising
Aging
Aging Model
Alzheimer's Disease Model
Animal Behavior
Animal Husbandry
Artificial Intelligence (AI)
Binding Competitions
Binding Surface Determination
Bioinformatics
Blood Collection
Blood-Brain Barrier Analysis
Brain Injection
Budgeting
Business Development
Cell Therapy
Cell Type Staining
Circular mRNA Production
Click Chemistry
Clinical Development
Clinical Pharmacology
Clinical Trials
Colitis Model
Crystallography
DNA Purification
Dissociation Constant (KD) determination
Drug Formulation
Equilibrium Binding
Förster resonance energy transfer (FRET)
GMP Sourcing
Gene Therapy
Genotyping
High-Performance Liquid Chromatography (HPLC)
Human Cases Studies
Immunocytochemistry
Immunohistochemistry
Inflammation Analysis
Inflammatory Cell Staining
Intraperitoneal Injection
Isothermal Titration Calorimetry (ITC)
Kidney Disease Model
Lentivirus Production
Lipid Nanodiscs
Lipid Nanoparticle Production
Lipid/LNP Quality Analysis
Live Cell Imaging
Liver Carcinoma Model
Liver Disease Model
Lung Fibrosis Model
Machine Learning
Mammalian Cell Cloning
Mammalian Cell Culture
Mammalian Cell Transfection
Mammalian Surgery
Mass Spectrometry
Medical Devices
Melanoma Model
Meta-analysis
Negotiation
Neurogenesis
Nuclear Magnetic Resonance (NMR)
Pharmacokinetics
Plasma Transfusions
Polymerase Chain Reaction (PCR)
Portal Vein Injection
Pre-clinical Studies
Project Planning
Promo
Protein Arrays
Protein Expression
Protein Mutagenesis
Protein Purification
Protein Structure Analysis
Public Relations
Pull-Downs
QuPath/ImageJ
Quantitative polymerase chain reaction (qPCR)
RNA Isolation
Regulatory Affairs
Regulatory Strategy
Regulatory Submissions
Rejuvenation
Retro-orbital Injection
Stable Cell Line Generation
Stereotactic Injection
Strategy
Subcutaneous Injection
Tail Vein Injection
Team Building
Team Leadership
Technical Leadership
Tissue Collection
Tissue Culture
Toxicology
Transgenic Construction
Ultracentrifugation Fractionation
Western Blotting
mRNA Production
mRNA Quality Analysis
Kyle Brewer Summary
Kyle Brewer, based in Palo Alto, CA, US, is currently a Chief Therapeutics Officer at Ainnocence. Kyle Brewer brings experience from previous roles at Stanford University, ETTA Biotechnology and Rejuvenation Technologies Inc.. Kyle Brewer holds a 2007 - 2014 PhD Molecular Biophysics @ UT Southwestern Medical Center. With a robust skill set that includes Adeno-associated virus (AAV) Production, Advertising, Aging, Aging Model, Alzheimer's Disease Model and more. Kyle Brewer has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Kyle Brewer?
Find contact details for 700 million professionals.